FindTrial
Sign In

Study on the Predictive Value of Artificial Intelligence Combined with Multimodal Magnetic Resonance Imaging for Malignant Risk Stratification of Ovarian Tumors

Study on the Predictive Value of Artificial Intelligence Combined with Multimodal Magnetic Resonance Imaging for Malignant Risk Stratification of Ovarian Tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116646
Enrollment
Unknown
Registered
2026-01-13
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian tumor

Interventions

Gold Standard:Pathology
Index test:MRI

Sponsors

The third affiliated hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Confirmed by pathology as ovarian tumor; 2.The interval between MRI examination and surgery is within 1 month;

Exclusion criteria

Exclusion criteria: 1.Cases with uncertain histopathological results; 2.Incomplete MRI examination sequence or poor image quality; 3.History of ovarian cancer or pelvic radiotherapy or chemotherapy in the past;

Design outcomes

Primary

MeasureTime frame
Tumor nature;Accuracy;—

Secondary

MeasureTime frame
Sensitivity;Specificity;—

Countries

China

Contacts

Public ContactTan Shifang

The third affiliated hospital of Zhengzhou University

156249352@qq.com+86 371 6690 3034

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026